Cancer Cytopathology
Overview
Cancer Cytopathology is a renowned peer-reviewed journal that focuses on the field of cytopathology, specifically the diagnosis and management of cancer through the examination of cells. It publishes cutting-edge research, clinical studies, and case reports, providing valuable insights into the latest advancements in cancer detection, classification, and treatment. The journal serves as a vital resource for pathologists, oncologists, and researchers dedicated to improving cancer diagnosis and patient care.
Details
Details
Abbr.
Cancer Cytopathol
Start
2010
End
Continuing
Frequency
Bimonthly
p-ISSN
1934-662X
e-ISSN
1934-6638
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 5296
68
SJR / Ranks: 3862
991
CiteScore / Ranks: 3323
6.50
JIF / Ranks: 2884
3.4
Recent Articles
1.
Goulart R, Nayar R, Lorey T, Joste N, Stoler M
Cancer Cytopathol
. 2025 Mar;
133(4):e70006.
PMID: 40055959
Because of many factors, the landscape of cervical cancer prevention is again at a pivot point within the United States. Primary human papillomavirus (HPV) screening has been recommended as the...
2.
Dhiman B, Kundu R, Mitra S, Kalra N, Premkumar M, Duseja A, et al.
Cancer Cytopathol
. 2025 Mar;
133(4):e70009.
PMID: 40045688
Background: Hepatocellular carcinoma (HCC) may be diagnosed and further subclassified in surgical specimen as per the recent World Health Organization (WHO) classification into several distinct subtypes with prognostic implications. The...
3.
Nelson B, Faquin W
Cancer Cytopathol
. 2025 Mar;
133(3):e70002.
PMID: 40034081
No abstract available.
4.
5.
Thomas K, Trinh H, Fei A, Khazai L, Sun H, Gan Q
Cancer Cytopathol
. 2025 Feb;
133(3):e70004.
PMID: 39992713
Background: Although histologic and fine-needle aspiration cytologic features of angiosarcoma are well established, little is known about its cytologic features in fluids. This study presents the cytomorphologic features of 22...
6.
Acanfora G, Iaccarino A, Cerbelli B, Di Cristofano C, Bellevicine C, Barberis M, et al.
Cancer Cytopathol
. 2025 Feb;
133(3):e70003.
PMID: 39992702
Introduction: The aim of this project is to assess interobserver agreement for programmed death-ligand 1 (PD-L1) scoring on of non-small cell lung cancer (NSCLC) on cytological specimens in a large-scale...
7.
Tannous E, Malik S, Gilani S
Cancer Cytopathol
. 2025 Feb;
133(2):e70000.
PMID: 39912378
Background: Pericardial effusion can be due to any etiology but may cause significant morbidity and mortality; however, malignant effusions are rare, and accurate and timely diagnosis is essential for appropriate...
8.
Hou T, Lin X
Cancer Cytopathol
. 2025 Feb;
133(2):e22933.
PMID: 39912368
Background: TFE3-rearranged renal cell carcinoma (TFE3-rRCC) harbors gene fusions involving TFE3 with one of many different partner genes. Because of their diverse morphologies, the differential diagnosis is broad and challenging....
9.
Sable M, Panda M, Acharya P, Mishra P, Purkait S, Sethy M, et al.
Cancer Cytopathol
. 2025 Feb;
133(2):e22936.
PMID: 39902551
Background: Fine-needle aspiration cytology (FNAC) has been used as the first line approach to lymphadenopathy, which is a common presentation in pediatric age group. The Sydney system for reporting of...
10.
Kwan M, Pitman M, Zhang M
Cancer Cytopathol
. 2025 Jan;
133(2):e22935.
PMID: 39865498
Background: Major mutations (e.g., KRAS, GNAS, TP53, SMAD4) in pancreatic cyst fluid (PCF) are useful for classifying and risk stratifying certain cyst types, particularly in cases with nondiagnostic cytology. However,...